KLK3 and prostate cancer: The findings presented herein significantly reinforce our previous finding (Cosma et al., 2017) that complementing the PSA prediction model with a subset of flow cytometry-based phenotypic predictors can significantly increase the accuracy of the initial prostate cancer test and reduce misclassification.